Cencora to Acquire Majority Stake in OneOncology from TPG
December 15, 2025
Cencora, Inc. entered into a definitive agreement to acquire the majority of the outstanding equity interests it does not already own in OneOncology from TPG and other shareholders. The transaction is valued at an enterprise value of $7.4 billion, with expected close by the end of Cencora’s fiscal 2026 second quarter subject to customary regulatory approvals.
- Buyers
- Cencora, Inc.
- Targets
- OneOncology
- Sellers
- TPG, Other shareholders of OneOncology
- Industry
- Healthcare Services
- Location
- Tennessee, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
TPG and AmerisourceBergen Acquire OneOncology from General Atlantic
April 20, 2023
Healthcare Services
TPG has agreed to acquire a majority interest in OneOncology and AmerisourceBergen will take a roughly 35% minority stake for approximately $685 million, valuing OneOncology at $2.1 billion. OneOncology's affiliated practices, physicians, and management will retain minority ownership as the parties form a new joint venture; the network includes over 900 affiliated providers across 14 states and the deal is expected to close by the end of September 2023.
-
Cencora To Acquire Retina Consultants of America in $4.6 Billion Deal
November 10, 2024
Healthcare Services
Cencora entered into a definitive agreement to acquire Retina Consultants of America (RCA), a leading retina specialist management services organization (MSO), from Webster Equity Partners. The deal values RCA at approximately $4.6 billion in cash, with additional potential contingent consideration of up to $500 million, and is expected to close subject to customary regulatory approvals.
-
Cencora and Covetrus to Merge with MWI Animal Health
February 18, 2026
Healthcare Services
Cencora and Covetrus have entered into a definitive agreement to merge Covetrus with MWI Animal Health (MWI), creating a comprehensive animal health platform. The transaction values MWI at an enterprise value of $3.5 billion, with Cencora receiving cash and preferred equity proceeds while retaining a non-controlling 34.3% common equity stake in the combined company.
-
TPG Completes Majority Investment in iNova Pharmaceuticals
October 31, 2022
Pharmaceuticals
TPG (through its Asia platform) completed a majority investment in iNova Pharmaceuticals, a multinational consumer health and pharmaceutical company, with existing investor Pacific Equity Partners re-investing as a minority co-investor. The deal will support iNova's regional expansion and growth strategy across Southeast and North Asia, and fund channel expansion, product-in-fill and technology investments.
-
Advent International Acquires Majority Stake in Encora
December 21, 2021
IT Services
Advent International has acquired a majority stake in Encora, a global digital engineering and software product development services provider. Warburg Pincus, the prior majority shareholder, retains a minority stake; Advent will partner with Encora's management to accelerate global growth, expand capabilities, and pursue targeted M&A.
-
CD&R and TPG Capital to Acquire Covetrus in ~$4B Deal
May 25, 2022
Healthcare Services
Covetrus entered into a definitive agreement to be acquired by funds affiliated with Clayton, Dubilier & Rice (CD&R) and TPG Capital for $21.00 per share in cash, implying an enterprise value of approximately $4 billion. The transaction is expected to close in the second half of 2022, subject to regulatory approvals and Covetrus shareholder approval, after which Covetrus will become a private company.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.